Skip to main content
Caplight Logo









PetalMD

PetalMD

Private
CanadaHealthcare & Life Scienceshttp://www.petal-health.com/en/

Last Round

Debt

Oct 3, 2019

Company Overview

PetalMD operates in Healthcare & Life Sciences and is based in Canada. Its latest recorded funding round was a Debt round in October 2019.

PetalMD is a healthcare technology company that provides cloud-based medico-administrative solutions, including physician scheduling, patient booking, and secure communication tools for healthcare professionals and institutions.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics, Patient Engagement, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PetalMD Comparables

Compare PetalMD with similar companies based on industry and business-model similarity.

PetalMD comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mesh AI
84%
Lantum
78%
Andgo Systems
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PetalMD Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 3, 2019
DebtMay 29, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

PetalMD Investors

Notable investors and investment history

PetalMD investors
InvestorRounds
Canadian Technology AcceleratorAccelerator
BDC CapitalDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 192% MoM, reaching 6.1K.

  • Jul 6, 2025

    Monthly visitors grew 61% MoM, reaching 8.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

PetalMD Filings

Explore SEC and related filing metadata, where available.

PetalMD filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PetalMD's valuation, stock price, and market status.

Is PetalMD a public or private company?

PetalMD is a private company.

What is the current stock price of PetalMD?

PetalMD is a private company, so its shares have no public market price. Caplight tracks PetalMD's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PetalMD worth (valuation)?

Valuation information for PetalMD is not publicly available.

Can I buy PetalMD stock?

PetalMD shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PetalMD's last funding round?

PetalMD's most recent funding round was Debt on October 3, 2019.

Who are the main investors in PetalMD?

Key investors in PetalMD include BDC Capital.

Will PetalMD IPO soon?

No public IPO plans have been announced for PetalMD.

How can I track PetalMD secondary market activity?

Caplight tracks bids, offers, and trades in PetalMD's shares on secondary markets.

Firmographic Details

HeadquartersCanada
Employee Range2
Year Founded2009
Last FundingOct 3, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?